Healthcare Contract Business Development Organization

 

SCIENTEX Group is a renowned healthcare focused CBDO presenting 13 international business awards with a global footprint thanks to +110 achieved deals in track record.

 

SCIENTEX Group, acting as a transition management company dedicated to healthcare startups, is covering mainly financing & business development matters, on sell & buy side: from seed capital to public offerings & follow-on financings, M&A, business development & licensing, R&D partnering.

 SCIENTEX has developed 4 products & services in order to boost all corporate activities, by leveraging the track record of its two founders (+110 deals since 1999 including financing, R&D partnering, BusDev & licensing, IPOs, M&A, M&S on both sell & buy sides & 33 missions since 2006 & +26 board member position since 1999) :  

  • SCIENTEX = Healthcare hands-on & executive support covering CFO & CBO functions, holding of billing, thus avoiding high costs & taxes, heaviness, sick leaves, holidays and legal constraints of the french pharma legal labor agreement.
  • BIOTECHNEWS = corporate & PR news push services covering the healthcare market thanks to a large contact database updated monthly including +81 000 industrial healthcare dealmakers & +3500 tech journalists and +10 000 inside financing.
  • BIOFOCUS = a >20 Go data analysis & market intelligence database focused on healthcare market; sourced, built and updated monthly from main market intelligence providers & investment banks.
  • BIOPHARMACAPITAL = Financing operations from seed capital to public offerings, follow-on & Investor Relations supportsbased on our contact database : +6000 contacts inside public & private equity, french speaking family office & business angels, +3500 wealth managers and our track-record as venture capitalist during 10 years and our last IPO & follow-on financings (2014-18) with CROSSJECT.

Thanks to a highly pragmatic approach fully dedicated to milestones achievments, SCIENTEX's associates are structured to work 60% more (2430 hours/year) than the 1529 hours, average working time in Europe. Thanks to its low cost fees, SCIENTEX will allow its clients to reduce their labor costs compared to FTE. Each of the 2 associates of SCIENTEX are limiting their supports to 2 clients max in parallel in order to guarantee their full intensive, full time , and fully dedicated supports. Generally speaking, for transition management missions, SCIENTEX's associates are supporting operationally CFO+CBO functions on a day to day basis , working remotely and commuting internationally , without any outsourcing.

 

SCIENTEX DECK.pdf
Document Adobe Acrobat [1.4 MB]
Version imprimable Version imprimable | Plan du site
SCIENTEX and its subsidiary OCEAN5 - Villa GOADIK , 49 avenue du Littoral 44380 PORNICHET - FRANCE - email : tm@scientex.eu - tm@ocean5.fr - skype id : timotheemuller - french mobile : +33 645 523 540 - Join our +55 000 connections and followers on linkedin :fr.linkedin.com/in/timotheemuller - https://www.facebook.com/GOADIK